---

$9.96

-0.3150 ( -3.07% ) 23.1K

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-11-14	Buy	100000.00	HEIDEN WILLIAM K
2023-11-14	Buy	446825.00	DOBMEIER ERIC
2023-08-18	Sale	-3202.00	Joshi Manher
2023-08-18	Sale	-21432.00	Touchon Pascal
2023-08-18	Sale	-5050.00	Murugan Amar
2023-08-18	Sale	-6408.00	Hyllengren Eric J
2023-08-18	Sale	-2788.00	Henrich Jill
2023-08-18	Sale	-5849.00	Nguyen AnhCo